First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
FDA announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Drugs & Pharmacology | Ebola | Ebola Vaccine | International Medicine & Public Health | Vaccines